Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Treatment of Diffuse Systemic Sclerosis

NCT01093885 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT01093885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01093885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Treatment of Diffuse Systemic Sclerosis
Lead sponsor
University of Pennsylvania
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2010
Completion date
July 31, 2016
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma, systemic sclerosis